determining the potential of ropeginterferon alfa-2b in polycythemia vera
Published 6 years ago • 1.8K plays • Length 5:17Download video MP4
Download video MP3
Similar videos
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
6:15
interferon’s role in treating polycythemia vera
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
3:19
targeting jak2 v617f vaf in polycythemia vera & the efficacy of ropeginterferon alfa-2b
-
1:15
dr. kambhampati on ropeginterferon alfa-2b in myeloproliferative neoplasms
-
16:41
ropeginterferon alfa-2b for the treatment of low-risk patients with polycythemia vera
-
1:11
dr. hoffman on the current treatment paradigm of polycythemia vera
-
4:04
polycythemia vera: monitoring patients
-
3:00
ropeginterferon alpha-2b as an effective treatment against pv
-
2:06
clinical updates on the use of ropeginterferon for polycythemia vera
-
1:42
dr. hoffman on the mechanism of action of ptg-300 in polycythemia vera
-
3:10
promising trials in polycythemia vera
-
1:30
dr. hoffman on the design of an ongoing trial testing ptg-300 in polycythemia vera
-
2:41
clinical control of polycythemia vera
-
22:39
besremi (ropeginterferon alfa-2b-njft) injection for polycythemia vera (pv)
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
1:42
dr. yacoub on pegylated interferon treatment for pv
-
2:40
safety and efficacy of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis
-
2:05
ropeg in polycythemia vera: long-term proud-pv and conti-pv results